Acute lymphoblastic leukemia, childhood
Other Names for this Disease
- Childhood acute lymphoblastic leukemia
See Disclaimer regarding information on this site. Some links on this page may take you to organizations outside of the National Institutes of Health.
On this page
(Bristol-Myers Squibb Pharmaceutical Research Institute)
The FDA has approved this product to be used in this manner.
|Induction therapy in patients with refractory childhood acute lymphoblastic leukemia when used in combination with other approved anticancer agents.|
|More Information about this product||
Drug Information Portal
Medline Plus Health Information